Skip to content

Search the library by company, product or topic.

↵open↑↓navigateescclose
Made byCureApp

CureApp SC

Prescription therapeutic app and CO checker to assist smoking cessation treatment of patients with nicotine dependence, approved in Japan in 2020.

sc.cureapp.com

At a glance

Type
Patient app
Platforms
iOS · Android · Device
Who it’s for
Patients and physicians
Where it’s available
Japan
Sources cited
3
In the library since
24 September 2026
Regulatory status
Japanese approval, PMDA list August 2020 (review 28 May 2020): assistance in smoking cessation treatment of patients with nicotine dependence; approval number 30200BZX00271000 as stated by the company.As recorded from the regulator or the company, with its attribution.

What it does

CureApp SC pairs a patient app with a carbon monoxide (CO) checker. Its official site for medical professionals gives approval number 30200BZX00271000, the general name smoking cessation treatment support system, and classification as a managed and specially maintained medical device, and says the app can be downloaded from Google Play and the App Store.

Independent evidence

Established from a source other than the company.

The PMDA review report (review of 28 May 2020, deliberation of 19 June 2020) gives the brand name CureApp SC Digital Therapeutic and CO Checker for Nicotine Dependence, the intended use of assisting smoking cessation treatment of patients with nicotine dependence, and approval without designation for a use-results survey; the PMDA's list gives the approval as August 2020. The approval number is as the company states it; the ministry's approval notice was not read.

What the company says

The company’s own statements, attributed to it and not presented as established fact.

The company reports a domestic phase III trial with continuous abstinence from weeks 9 to 24 of 63.9% against 50.5%. Pricing is not recorded.

Written about in the Journal

Journal

More from CureApp

Similar products

More of Recent HealthTech